A CITF-funded study, published in Transplantation and Cellular Therapy, found that a fourth dose of the COVID-19 vaccine is highly immunogenic (induces a good immune response) and safe in people who have a received an allogeneic Hematopoietic Stem Cell Transplant (HSCT).